key articles
4th EMUC preview: role of metastasectomy in the era of targeted therapy
Friday, 9 November 2012- Metastasectomy is often part of an overall treatment in patients with metastatic kidney cancer. Although the role of metastasectomy was studied in the immunotherapy era, it’s place in the era of targeted...
By Joel Vega
12th CEM: management issues in renal cell cancer
Monday, 15 October 2012- Management issues in renal cell cancer particularly the role of biopsy, active surveillance, partial nephrectomy and palliative surgery were taken up in the second-day plenary session of the...
By Joel Vega
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas
Monday, 8 October 2012- E. Xylinas and colleagues conducted a study to identify predictive factors and assess the impact on oncological outcomes of intravesical recurrence after radical nephroureterectomy (RNU) in upper tract...
Posted by: JV
New trial results on pazopanib and temsirolimus: key implications for patients
Thursday, 4 October 2012- New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology held in...
Posted by: JV
Oncological and functional outcomes after radical nephrectomy for kidney cancer
Monday, 1 October 2012- T.Sejima and colleagues conducted a study to investigate mortality rates and to comprehensively analyze prognostic indicators after radical nephrectomy for renal cell carcinoma. They published their...
Filed by: JV
US study uses enzyme in new blood test that may guide kidney cancer treatment
Thursday, 16 August 2012- A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute.
The...
Posted by: JV
Inflammatory pathways play vital role in link between depressive symptoms and cancer survival
Thursday, 9 August 2012- Research from The University of Texas MD Anderson Cancer Center has found that symptoms of depression in patients with newly diagnosed metastatic kidney cancer are associated with survival and...
Filed by: JV
C-reactive protein in advanced mRCC: usefulness in identifying patients to benefit from initial nephrectomy
Monday, 6 August 2012- C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to...
Filed by: JV
Laparoendoscopic single-site (LESS) partial nephrectomy short-term outcomes
Tuesday, 17 July 2012- Laparoendoscopic single-site (LESS) surgery has been used by urologists for a broad range of operations including LESS partial nephrectomy (LESS-PN). To date, experiences of LESS-PN have been presented as...
Filed by: JV
Assessing laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors
Thursday, 5 July 2012- M. Smaldone and colleagues conducted a study to assess the impact of laparoscopy on usage of partial nephrectomy (PN) by comparing national usage trends in patients undergoing surgery for localized renal...
Filed by: JV
